Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

352
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
352
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comprehensive graph neural network method for predicting triplet motifs in disease-drug-gene interactions.

Bioinformatics (Oxford, England)·2025
Same author

AVBAE-MODFR: A novel deep learning framework of embedding and feature selection on multi-omics data for pan-cancer classification.

Computers in biology and medicine·2024
Same author

Predicting lncRNA-protein interactions with bipartite graph embedding and deep graph neural networks.

Frontiers in genetics·2023
Same author

TLCrys: Transfer Learning Based Method for Protein Crystallization Prediction.

International journal of molecular sciences·2022
Same author

LR-GNN: a graph neural network based on link representation for predicting molecular associations.

Briefings in bioinformatics·2021
Same author

OTNet: A CNN Method Based on Hierarchical Attention Maps for Grading Arteriosclerosis of Fundus Images with Small Samples.

Interdisciplinary sciences, computational life sciences·2021
Same journal

An EEG-Based Framework for Sleep Quality Assessment and Modulation with Conditional Convolutional Diffusion Modeling.

IEEE journal of biomedical and health informatics·2026
Same journal

Substantia Nigra Imaging Biomarker Segmentation for Parkinson's Disease Diagnosis via Transformer-Enhanced U-Net Architecture.

IEEE journal of biomedical and health informatics·2026
Same journal

E-TIME: Emotion Trend Inspired Multi-task Sparse Mask Neural Network for Multimodal Emotion Recognition.

IEEE journal of biomedical and health informatics·2026
Same journal

Cross-Modal Feature Adapter for Few-Shot Human Activity Recognition.

IEEE journal of biomedical and health informatics·2026
Same journal

Cross Domain Self-Prompting SAM2 for Intraoperative OCT Video Segmentation.

IEEE journal of biomedical and health informatics·2026
Same journal

Multi-Property Optimization of Antimicrobial Peptides Using Reinforcement Learning and Conditional Independence Regularization.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

A Dual-Modality Complex-Valued Fusion Method for Predicting Side Effects of Drug-Drug Interactions Based on Graph

Chuanze Kang, Han Zhang, Yanbin Yin

    IEEE Journal of Biomedical and Health Informatics
    |July 11, 2024
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces DMCF-DDI, a novel computational method for predicting drug-drug interaction (DDI) side effects by fusing multi-modal drug features. The approach enhances prediction accuracy using complex-valued representations and graph convolutional networks.

    More Related Videos

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.2K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    11.8K

    Related Experiment Videos

    Last Updated: Jun 21, 2025

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.5K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.2K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    11.8K

    Area of Science:

    • Computational chemistry
    • Pharmacology
    • Bioinformatics

    Background:

    • Predicting drug-drug interaction (DDI) side effects is crucial for therapeutic efficacy.
    • Integrating multi-modal drug features presents challenges in feature fusion for DDI prediction.

    Purpose of the Study:

    • To propose an efficient computational method, DMCF-DDI, for predicting DDI side effects.
    • To enhance DDI representations using complex-valued fusion across modalities.

    Main Methods:

    • Utilized two Graph Convolutional Network (GCN) encoders for molecular structure and topological features.
    • Employed an asymmetric skip connection (ASC) for complex-valued drug pair representation (DPR) construction.
    • Applied complex-vector multiplication and Hermitian inner product for fusion and prediction.

    Main Results:

    • DMCF-DDI demonstrated superior performance in DDI side effect prediction compared to existing methods.
    • Achieved high prediction accuracy with a fusion operator having the lowest parameter count.
    • Validated the model's identification ability through a case study on common clinical side effects.

    Conclusions:

    • The proposed dual-modality complex-valued fusion method (DMCF-DDI) effectively predicts DDI side effects.
    • The asymmetric skip connection and complex-valued fusion align cross-modal representations, enhancing prediction.
    • The method offers a computationally efficient and accurate approach for DDI analysis.